SCHEMBL24438157

SCHEMBL24438157

COc1ccc(Cl)cc1C(=O)Nc1ccc(Oc2ccccc2)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.70
MEN1 O00255 5/20 0.67
KMT2A Q03164 5/20 0.67
PNLIP P16233 2/20 0.66
KCNMA1 Q12791 1/20 0.65
MAPT P10636 3/20 0.64
KDM4E B2RXH2 3/20 0.64
HPGD P15428 2/20 0.64
HSD17B10 Q99714 2/20 0.64
NPSR1 Q6W5P4 2/20 0.63
GAA P10253 1/20 0.63
HTT P42858 1/20 0.63
STK39 Q9UEW8 1/20 0.62
NPC1 O15118 4/20 0.62
POLB P06746 1/20 0.62
AHR P35869 1/20 0.62
HDAC8 Q9BY41 1/20 0.59
TP53 P04637 1/20 0.58
TSHR P16473 1/20 0.58
RAB9A P51151 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30692657 1.00 ALDH1A1 (0.70) ALDH1A1MEN1KMT2APNLIPKCNMA1
SCHEMBL30692658 0.94 ALDH1A1 (0.76) ALDH1A1MEN1KMT2APNLIPKCNMA1
SCHEMBL24438042 0.94 ALDH1A1 (0.76) ALDH1A1MEN1KMT2APNLIPKCNMA1
SCHEMBL17740367 0.90 ALDH1A1 (0.77) ALDH1A1MEN1KMT2AKCNMA1MAPT
SCHEMBL24438298 0.89 PNLIP (0.79) ALDH1A1MEN1KMT2APNLIPMAPT
SCHEMBL30692674 0.89 PNLIP (0.79) ALDH1A1MEN1KMT2APNLIPMAPT
SCHEMBL24438368 0.88 ALDH1A1 (0.80) ALDH1A1MEN1KMT2APNLIPKCNMA1
SCHEMBL30692670 0.88 ALDH1A1 (0.80) ALDH1A1MEN1KMT2APNLIPKCNMA1
SCHEMBL24438616 0.85 MAPT (0.64) ALDH1A1MEN1KMT2AKCNMA1MAPT
SCHEMBL11515491 0.84 ALDH1A1 (0.82) ALDH1A1MEN1KMT2AKCNMA1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230406831-A1 COMPOUNDS AND METHODS OF INHIBITING BACTERIAL CHAPERONIN SYSTEMS THE TRUSTEES OF INDIANA UNIVERSITY 2023-12-21 US disclosed
EP-4243799-A1 COMPOUNDS AND METHODS OF INHIBITING BACTERIAL CHAPERONIN SYSTEMS The Trustees of Indiana University (US) 2023-09-20 EP disclosed
WO-2022103572-A1 COMPOUNDS AND METHODS OF INHIBITING BACTERIAL CHAPERONIN SYSTEMS THE TRUSTEES OF INDIANA UNIVERSITY (US) 2022-05-19 WO disclosed
WO-2022103572-A1 COMPOUNDS AND METHODS OF INHIBITING BACTERIAL CHAPERONIN SYSTEMS THE TRUSTEES OF INDIANA UNIVERSITY (US) 2022-05-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230406831-A1 COMPOUNDS AND METHODS OF INHIBITING BACTERIAL CHAPERONIN SYSTEMS HSP90B1, HSPBP1, HSP90AB1 ALDH1A1 4065/4885MEN1 4702/4885KMT2A 4732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.